KIND, CAP Research Center
Stockholm, 11330, Sweden
NCT Number: NCT03196713
The objective of this study is to examine the significance of knowledge of autism spectrum disorder (ASD), and early intensive behavioral intervention, as well as trust in EIBI, adequate assessment of EIBI quality, and EIBI supervision on EIBI intervention outcome in ASD.
Looking for future studies?
Notify Me2 year–6 year
All sexes
Interventional
Not applicable
Stockholm, 11330, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Other names: Applied Behavior Analysis
Time frame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
Time frame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
Time frame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
Looking for future studies?
Notify MeKarolinska Institutet
Other
Quality and Efficacy of Early Intensive Autism Intervention: a Matter of Trust, Knowledge, and Supervision?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03279471
Anxiety, Anxiety Disorders
Sacramento, California, United States
View Trial DetailsNCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT05910502
Autism, Autism Spectrum Disorder
Atherton, California, United States
View Trial DetailsNCT06361147
Autism Spectrum Disorder, Autistic Disorder
Heraklion, Crete, Greece
View Trial Details